Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma
Folia Biologica · 2025
DOI: 10.14712/fb2025071020073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Biologica, 2025. Verfasst von Motaz Fadul und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Medulloblastoma, Mutation, Cerebellar Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Medulloblastoma (MB) in children is associated with distinct molecular subgroups, reflecting substantial biological heterogeneity. The presence of isocitrate dehydrogenase 1 ( IDH1 ) and IDH2 mutations in paediatric MB has been rarely reported and not routinely investigated. Our study included 23 samples from paediatric patients diagnosed with MB. Hotspot alterations at codons IDH1 R132 and IDH2 R172 were examined using Sanger sequencing following polymerase chain reaction (PCR). The mean age of the patients was 10 years (SD: 4.25), comprising 17 males and 6 females. All cases exhibited classical histological features of MB. β-Catenin expression was observed in four cases (17.4 %), while 19 cases (82.6 %) showed no expression. No statistically significant differences in progression-free survival (PFS) were found between MBs with positive or negative β-catenin expression (P = 0.6). Radiotherapy alone was administered to four patients (17.4 %), while 19 patients (82.6 %) received combined radiotherapy and chemotherapy. The median PFS was 383 days (1 year and 18 days). IDH1 R132 or IDH2 R172 hotspot mutations were not detected in any of the samples. The absence of IDH1 or IDH2 mutations in paediatric MB may be attributed to differences in mutational profiles and cellular origins in childhood MB, despite its histomolecular similarities with adult MB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
- Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Prince Saud Al Faisal Street, Jeddah, Saudi Arabia.
- Department of Pathology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Section of Neurosurgery, Department of Surgery, King Abdulaziz Medical City, Makkah Road, Jeddah, Saudi Arabia.
- Department of Surgery, Faculty of Medicine, King Abdulaziz University, Abdullah Suleiman Street, Jeddah, Saudi Arabia.
Zitieren
APA
Fadul, M., Baeesa, S., Alkhotani, A., Fathaddin, A. A., Lary, A. I., Addass, B., Alsinani, T., Bamaga, A., Albeshri, A., Karami, M. M., Abutalib, M. A., & Kurdi, M. (2025). Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma. Folia Biologica. https://doi.org/10.14712/fb2025071020073
Vancouver
Fadul M, Baeesa S, Alkhotani A, Fathaddin AA, Lary AI, Addass B, et al. Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma. Folia Biologica. 2025. doi:10.14712/fb2025071020073
BibTeX
@article{Fadul2025,
author = {Fadul, Motaz and Baeesa, Saleh and Alkhotani, Alaa and Fathaddin, Amany A and Lary, Ahmed I and Addass, Bassam and Alsinani, Taghreed and Bamaga, Ahmed and Albeshri, Ahmad and Karami, Mohammed M and Abutalib, Mohammed A and Kurdi, Maher},
title = {Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma},
journal = {Folia Biologica},
year = {2025},
doi = {10.14712/fb2025071020073}
}
EUVIMED